AXIM Biotechnologies, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AXIM research report →
Companywww.aximbiotech.com
AXIM Biotechnologies, Inc. develops and sells diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and oncology. The company is developing rapid diagnostic tests, which measure the levels of functional neutralizing antibodies that prevent SARS-CoV-2 from attaching to human cells; serological diagnostic test, which detect neutralizing antibodies that measure adaptive immune response to the SARS-CoV-2 virus; and tests for management of COVID-19 Patients to detect biomarkers related to inflammation.
- CEO
- Catalina Valencia
- IPO
- 2014
- Employees
- 6
- HQ
- San Diego, CA, US
Price Chart
Valuation
- Market Cap
- $2.04M
- P/E
- -3.88
- P/S
- 0.00
- P/B
- -0.19
- EV/EBITDA
- 155.48
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 4.91%
- ROIC
- 32.31%
Growth & Income
- Revenue
- $0 · -100.00%
- Net Income
- $-1,043,083 · 70.30%
- EPS
- $-0.00 · 71.82%
- Op Income
- $-1,319,652
- FCF YoY
- 20.01%
Performance & Tape
- 52W High
- $0.03
- 52W Low
- $0.00
- 50D MA
- $0.01
- 200D MA
- $0.01
- Beta
- -0.24
- Avg Volume
- 214.51K
Get TickerSpark's AI analysis on AXIM
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jan 30, 24 | Valencia Catalina | buy | 1,086,216 |
| Mar 15, 24 | HUEMOELLER JOHN WALTER II | other | 250,000 |
| Mar 15, 24 | Valencia Catalina | other | 7,837,500 |
| Mar 15, 24 | Schroeder Blake | other | 35,000 |
| Mar 15, 24 | Cunningham Robert L | other | 35,000 |
| Mar 15, 24 | Scott Timothy Richard | other | 35,000 |
| Mar 15, 24 | O'Rourke Peter | other | 35,000 |
| Mar 15, 24 | MALASEK ROBERT | other | 53,500 |
| Mar 15, 24 | HUEMOELLER JOHN WALTER II | other | 1 |
| May 23, 23 | Phinney Kurt | other | 2,000,000 |
Our AXIM Coverage
We haven't published any research on AXIM yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate AXIM Report →